MVZ HPH Launches Cutting-Edge ctDNA Blood Test for Cancer Monitoring in Germany The MVZ HPH Institute introduces a revolutionary blood test for cancer monitoring in Germany, utilizing Haystack MRD technology to improve patient care.

MVZ HPH Launches Cutting-Edge ctDNA Blood Test for Cancer Monitoring in Germany #Germany #Hamburg #Haystack_MRD #MVZ_HPH #ctDNA_Blood_Test